Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatmentSean P Pitroda, Nikolai N Khodarev, Michael A Beckett, et al.
Molecular Cancer Therapeutics|September 26, 2014
CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathwayNaoya Saito, Keiichi Sakakibara, Takuji Sato, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12Tetsuro Kikuchi, Yasuharu Akasaki, Toshiaki Abe, et al.
Oncotarget|October 4, 2017
CBP501 suppresses macrophage induced cancer stem cell like features and metastasesNaoki Mine, Sayaka Yamamoto, Naoya Saito, et al.
Anti-Cancer Drugs|October 14, 2005
Chemo-inducible gene therapyJames J Mezhir, Hank Schmidt, Bakhtiar Yamini, et al.
The Lancet. Oncology|November 9, 2002
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapyRalph R Weichselbaum, Donald W Kufe, Samuel Hellman, et al.
Radiation Research|April 23, 2002
Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membraneMichael W Epperly, Christine A Sikora, Stacy J DeFilippi, et al.
Cancer Research|March 26, 2009
MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancerNikolai N Khodarev, Sean P Pitroda, Michael A Beckett, et al.
Molecular Cancer Therapeutics|August 12, 2011
CBP501-calmodulin binding contributes to sensitizing tumor cells to cisplatin and bleomycinNaoki Mine, Sayaka Yamamoto, Naoya Saito, et al.
Pageof 4